CHRISTOPHER HWANG, MD
Ophthalmology Physician · SAINT LOUIS, MO
Individual Active NPI 1477973113
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 599 | 12,870 | $7,882,766 | $2,128,243 | $1,674,815 |
| 2023 | 563 | 7,920 | $5,814,452 | $1,605,148 | $1,265,133 |
| 2022 | 244 | 1,366 | $734,865 | $305,397 | $242,424 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 6,900 | $35 | $28 |
| J0178 | Injection, aflibercept, 1 mg | 1,540 | $823 | $654 |
| 92134 | Imaging of retina | 1,473 | $42 | $31 |
| 67028 | Injection of drug into eye | 956 | $129 | $96 |
| J0177 | Injection, aflibercept hd, 1 mg | 417 | $332 | $264 |
| 92014 | Established patient complete exam of visual system | 293 | $131 | $95 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 260 | $215 | $171 |
| J2778 | Injection, ranibizumab, 0.1 mg | 249 | $156 | $124 |
| 92012 | Established patient problem focused exam of visual system | 220 | $93 | $65 |
| J9035 | Injection, bevacizumab, 10 mg | 123 | $72 | $54 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 117 | $170 | $120 |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 111 | $173 | $137 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 2020014796 | MO |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Missouri
- NPI 1831594233
- NPI 1578914974
- NPI 1689755209
- NPI 1992140958
- NPI 1194045245
- NPI 1699791913
- NPI 1659453637
- NPI 1801818653
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.